{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:42:55Z","timestamp":1787506975916,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s13300-020-00945-4","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T02:02:50Z","timestamp":1603677770000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec\u2013Liraglutide (Ideglira)"],"prefix":"10.1007","volume":"12","author":[{"given":"Luciano","family":"Zenari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Da Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"De Moliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Guazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Groppelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Bracaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Frison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalino","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bonsembiante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Lapolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"945_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/DMSO.S27528","volume":"5","author":"H Berlie","year":"2012","unstructured":"Berlie H, Hurren KM, Pinelli NR. Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review. Diabetes Metab Syndr Obes. 2012;5:165\u201374. https:\/\/doi.org\/10.2147\/DMSO.S27528.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"41","key":"945_CR2","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/dci18-0033","volume":"2018","author":"MJ Davies","year":"2018","unstructured":"Davies MJ, D\u2019Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;2018(41):2669\u2013701. https:\/\/doi.org\/10.2337\/dci18-0033.","journal-title":"Diabetes Care"},{"key":"945_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/dom.12025","volume":"15","author":"R Balena","year":"2013","unstructured":"Balena R, Hensley IE, Miller S, Barnett AH. Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature. Diabetes Obes Metab. 2013;15:485\u2013502. https:\/\/doi.org\/10.1111\/dom.12025.","journal-title":"Diabetes Obes Metab"},{"issue":"6 Suppl 1","key":"945_CR4","doi-asserted-by":"publisher","first-page":"6S28","DOI":"10.1016\/S1262-3636(16)30006-4","volume":"41","author":"B Cariou","year":"2015","unstructured":"Cariou B. Pleiotropic effects of insulin and GLP-1 receptor agonists: potential benefits of the association. Diabetes Metab. 2015;41(6 Suppl 1):6S28\u201335. https:\/\/doi.org\/10.1016\/S1262-3636(16)30006-4.","journal-title":"Diabetes Metab."},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"e3082","DOI":"10.1002\/dmrr.3082","volume":"35","author":"M Castellana","year":"2019","unstructured":"Castellana M, Cignarelli A, Brescia F, Laviola L, Giorgino F. GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35:e3082. https:\/\/doi.org\/10.1002\/dmrr.3082.","journal-title":"Diabetes Metab Res Rev"},{"key":"945_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-015-0260-x","volume":"14","author":"SK Paul","year":"2015","unstructured":"Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:100. https:\/\/doi.org\/10.1186\/s12933-015-0260-x.","journal-title":"Cardiovasc Diabetol"},{"key":"945_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/dom.13156","volume":"20","author":"L Tong","year":"2018","unstructured":"Tong L, Pan C, Wang H, Bertolini M, Lew E, Meneghini LF. Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: a longitudinal study of a US administrative claims database. Diabetes Obes Metab. 2018;20:831\u20139. https:\/\/doi.org\/10.1111\/dom.13156.","journal-title":"Diabetes Obes Metab"},{"key":"945_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pcd.2015.12.005","volume":"10","author":"E Hughes","year":"2016","unstructured":"Hughes E. IDegLira: Redefining insulin optimisation using a single injection in patients with type 2 diabetes. Prim Care Diabetes. 2016;10:202\u20139. https:\/\/doi.org\/10.1016\/j.pcd.2015.12.005.","journal-title":"Prim Care Diabetes"},{"key":"945_CR9","unstructured":"Novo Nordisk. Xultophy\u00ae Summary of Product Characteristics. 2017. www.medicines.org.uk\/emc\/medicine\/29493. Accessed 30 July 2020."},{"key":"945_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14740338.2017.1288715","volume":"16","author":"L Vedtofte","year":"2017","unstructured":"Vedtofte L, Knop FK, Vilsb\u00f8ll T. Efficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes. Expert Opin Drug Saf. 2017;16:387\u201396. https:\/\/doi.org\/10.1080\/14740338.2017.1288715.","journal-title":"Expert Opin Drug Saf"},{"key":"945_CR11","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.2337\/dc14-0785","volume":"37","author":"JB Buse","year":"2014","unstructured":"Buse JB, Vilsb\u00f8ll T, Thurman J, et al. Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira). Diabetes Care. 2014;37:2926\u201333. https:\/\/doi.org\/10.2337\/dc14-0785.","journal-title":"Diabetes Care"},{"key":"945_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S2213-8587(14)70174-3","volume":"2","author":"SCL Gough","year":"2014","unstructured":"Gough SCL, Bode B, Woo V, et al. Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes. Lancet Diabetes Endocrinol. 2014;2:885\u201393. https:\/\/doi.org\/10.1016\/S2213-8587(14)70174-3.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"945_CR13","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.2016.1252","volume":"315","author":"I Lingvay","year":"2016","unstructured":"Lingvay I, Manghi FP, Garc\u00eda-Hern\u00e1ndez P, et al. Effect of insulin glargine up-titration vs insulin degludec\/liraglutide on glycated hemoglobin levels in patients with uncontrolled type 2 diabetes: the DUAL V randomized clinical trial. JAMA. 2016;315:898\u2013907. https:\/\/doi.org\/10.1001\/jama.2016.1252.","journal-title":"JAMA"},{"key":"945_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2337\/dc17-1114","volume":"41","author":"LK Billings","year":"2018","unstructured":"Billings LK, Doshi A, Gouet D, et al. Efficacy and safety of IDegLira versus basal-bolus insulin therapy in patients with type 2 diabetes uncontrolled on metformin and basal insulin: the DUAL VII randomized clinical trial. Diabetes Care. 2018;41:1009\u201316. https:\/\/doi.org\/10.2337\/dc17-1114.","journal-title":"Diabetes Care"},{"key":"945_CR15","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/dom.12892","volume":"19","author":"SB Harris","year":"2017","unstructured":"Harris SB, Kocsis G, Prager R, et al. Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial. Diabetes Obes Metab. 2017;19:858\u201365. https:\/\/doi.org\/10.1111\/dom.12892.","journal-title":"Diabetes Obes Metab"},{"key":"945_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13300-016-0218-3","volume":"8","author":"S Linjawi","year":"2017","unstructured":"Linjawi S, Bode BW, Chaykin LB, et al. The efficacy of IDegLira (insulin degludec\/liraglutide combination) in adults with type 2 diabetes inadequately controlled with a GLP-1 receptor agonist and oral therapy: DUAL III randomized clinical trial. Diabetes Ther. 2017;8:101\u201314. https:\/\/doi.org\/10.1007\/s13300-016-0218-3.","journal-title":"Diabetes Ther"},{"key":"945_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/dme.13256","volume":"34","author":"HW Rodbard","year":"2017","unstructured":"Rodbard HW, Bode BW, Harris SB, et al. Safety and efficacy of insulin degludec\/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-na\u00efve people with Type 2 diabetes: the DUAL IV trial. Diabet Med. 2017;34:189\u201396. https:\/\/doi.org\/10.1111\/dme.13256.","journal-title":"Diabet Med"},{"key":"945_CR18","unstructured":"Novo Nordisk. Xultophy\u00ae Prescribing Information (PI). 2016. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/208583s000lbl.pdf. Accessed 31 July 2020."},{"key":"945_CR19","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1111\/dom.13840","volume":"21","author":"ML Morieri","year":"2019","unstructured":"Morieri ML, Rigato M, Frison V, et al. Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: a retrospective multicentre comparative effectiveness study. Diabetes Obes Metab. 2019;21:2542\u201352. https:\/\/doi.org\/10.1111\/dom.13840.","journal-title":"Diabetes Obes Metab"},{"key":"945_CR20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/dom.13182","volume":"20","author":"H Price","year":"2018","unstructured":"Price H, Bl\u00fcher M, Prager R, et al.. Use and effectiveness of a fixed-ratio combination of insulin degludec\/liraglutide (IDegLira) in a real-world population with type 2 diabetes: Results from a European, multicentre, retrospective chart review study. Diabetes Obes Metab. 2018;20:954\u201362. https:\/\/doi.org\/10.1111\/dom.13182.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"945_CR21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s13300-019-0673-8","volume":"10","author":"Z Taybani","year":"2019","unstructured":"Taybani Z, B\u00f3tyik B, Katk\u00f3 M, Gyimesi A, V\u00e1rkonyi T. Simplifying complex insulin regimens while preserving good glycemic control in type 2 diabetes. Diabetes Ther. 2019;10(5):1869\u201378. https:\/\/doi.org\/10.1007\/s13300-019-0673-8.","journal-title":"Diabetes Ther"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-020-00945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-020-00945-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-020-00945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T23:00:26Z","timestamp":1635202826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-020-00945-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s13300-020-00945-4","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}